Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal...

January 7, 2020

1/5
Please reload

Featured Posts

Potentia Pharmaceuticals Hosts Reception at the 2006 ARVO Annual Meeting in Fort Lauderdale

April 3, 2006

 

Potentia hosted a reception in Fort Lauderdale during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting. The event brought together the entire Potentia team and Scientific Advisory Board, along with collaborators and potential partners and introduced them to Potentia and its focused developmental timetable. The reception was a frank success and approximately 35 people attended.

 

 

Tags:

Please reload

NEWS

7910 Woodmont Avenue,Suite 1210
Bethesda, Maryland 20814, U.S.A. 
info@mlsvfund.com |   +1 301 298 5455

© 2018  by MASA Life Science Ventures, LP